CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines

The unraveling of Zosano Pharma has led to a drug delivery deal. With the company filing for bankruptcy in the wake of its rejection by the FDA, Emergex Vaccines has...
Continue Reading →
News

Pharmapack Report 2021: Digital data democratization, environmental factors & user experience driving device innovation in 2022

Ocular delivery and interactive packaging forecast to see big developments New findings in the Pharmapack Report 2021 are released ahead of Ph...
Continue Reading →
Volume 13 Issue 3

Small-Scale Batch Production for Clinical Gamma Scintigraphy Studies of Pharmaceuticals

Pharmaceutical gamma scintigraphy is a technique that has been adapted from clinical diagnostic applications to enable the in vivo fate of pharmaceutical dosage form...
Continue Reading →
Volume 13 Issue 3

New DPI Data Insights Shaping Future of Global Healthcare Needs

Innovative inhalation therapies and drug delivery are legacies of the COVID-19 pandemic, as pharma and biopharma formulators address growing demands for new healthca...
Continue Reading →
News

Next Breath Announces Injectable, Extractable and Leachable Services

Next Breath, a division of AptarGroup, Inc., is pleased to announce the extension of their cGMP analytical services to include development services for injectable de...
Continue Reading →
News

RDD 2018: Early Registration Deadline January 22

Now’s The Time to Plan to Participate, Register & Save.This readily accessible, major international symposium is where nasal and pulmonary product developers inn...
Continue Reading →
News

Pulmonary and Nasal Drug Delivery Experts to Attend ASAL RDD Europe 2017

Register now to attend the RDD Europe 2017 Scientific Conference to be held April 25-28, 2017, in Antibes, France. The Respiratory Drug Delivery (RDD®) Europe 2017 s...
Continue Reading →
News

Phillips-Medisize Creates a Manufacturing Center of Excellence for Connected Health and Drug Delivery Devices

Phillips-Medisize, a Molex company, announces its initial investment to expand the capabilities of the 380,000 square foot Molex Little Rock facility to include a FD...
Continue Reading →
News

Phillips-Medisize Exhibits During DDL2017

Phillips-Medisize will exhibit at the Drug Delivery to the Lungs Conference, which is taking place at Edinburgh International Conference Center on December 6-8, 2017...
Continue Reading →
News

Copley Scientific to showcase new TPK™ 2100 Critical Flow Controller for dry powder inhaler testing at DDL2017

Copley Scientific, the world’s leading manufacturer of inhaler test equipment, will be presenting its new 3rd generation Critical Flow Controller – the TPK™ 2100 – f...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026